Search Results
12 items found for "GPRC5D"
Posts (5)
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Downregulates Mucin 15 to Promote OvarianCancer Malignancy Bispecific antibodies targeting BCMA or GPRC5D
- 📰 GPCR Weekly News, June 17 to 23, 2024
orthostatic tachycardia syndrome The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Factor via HDAC5 in Depression GPCRs in Oncology and Immunology Structural Basis for the Recognition of GPRC5D
Other Pages (7)
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
< GPCR News < GPCRs in Oncology and Immunology Structural Basis for the Recognition of GPRC5D by Talquetamab G-protein-coupled receptor class C group 5 member D (GPRC5D), an orphan GPCR predominantly expressed microscopy, providing the basis for recognition of GPRC5D by the bispecific antibody. GPRC5D forms a symmetric homodimer with the interface between transmembrane helix (TM) 4 of one protomer The structure offers insights for optimizing antibody design against GPRC5D for relapsed or refractory
- The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
in Oncology and Immunology The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer Published date June 19, 2024 Abstract "GPRC5D is an atypical Class C orphan G protein-coupled Here, we present the structure of GPRC5D in complex with a preclinical-stage single-chain antibody (scFv Our structural analysis reveals that the GPRC5D presents a close resemblance to the typical Class C GPCRs Furthermore, we elucidate the binding site engaging a sizable extracellular domain on GPRC5D for scFv
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Several case studies of GPCR and other multi-pass transmembrane targets are presented, including GPRC5D